|
Featured Articles
-New Women's Product Line
-"The Calcium Paradox" - Vitamin K Commentary & Research Update by Dr. Mark Swanson, N.D.
What's New in May
-Women's Formulas: Breast Health Complete, Fem-Spectrum, Maca-3, Chaste tree (Vitex), Bladder Support Complex
-Specialty Products: HM Chelate, Pain Relieve, Muscle/Cramp Tension Formula
Product Highlights
-Read more about our weekly product specials
Featured Abstracts
-Higher intakes of the plant lignans, as well as exposure to the enterolignans enterodiol and enterolactone, promote breast cell health in women...*
-Maca extract supports healthy sexual desire, without altering serum testosterone or oestradiol levels...*
-Modified citrus pectin enhances arsenic, cadmium and lead excretion resulting from common, mild environmental exposure...*
-Chaste tree (Vitex) maintains healthy serum prolactin levels and breast comfort...*
-Calcium and vitamin D intake is associated with menstrual comfort, positive mood and water balance during the menstrual cycle...*
Frequently Asked Questions
-What Women's Formula Supports Comfort and Health throughout Menstrual, Perimenopausal and Menopausal Phases?
Quick Fact
-Modified Citrus Pectin
|
|  |
 |
The effect of modified citrus pectin on urinary excretion of toxic elements
This study was undertaken to evaluate the effect of modified citrus pectin (MCP) on the urinary excretion of toxic elements in healthy individuals. MCP is a reduced molecular weight pectin (weight-average molar mass = 15,400) that is mostly linear homogalacturonan with a 3.8% degree of esterification and approximately 10% rhamnogalacturonan II based on the presence of 2-keto-3-deoxy-octonic acid. Subjects ingested 15 g of MCP (PectaSol, EcoNugenics Inc., Santa Rosa, California 95407) each day for 5 days and 20 g on day 6. Twenty-four hour urine samples were collected on day 1 and day 6 for comparison with baseline. The urine samples were analysed for toxic and essential elements. In the first 24 h of MCP administration the urinary excretion of arsenic increased significantly (130%, p < 0.05). On day 6, urinary excretion was increased significantly for cadmium (150%, p < 0.05). In addition, lead showed a dramatic increase in excretion (560%, p < 0.08). This pilot trial provides the first evidence that oral administration of MCP increases significantly the urinary excretion of toxic metals in subjects with a 'normal' body load of metals. It is suggested that systemic chelation of toxic metals by MCP may in part be attributable to the presence of rhamnogalacturonan II, which has been shown previously to chelate metals. Eliaz I, Hotchkiss AT, Fishman ML, Rode D. Phytother Res. 2006 Oct;20(10):859-64.
For educational purposes only. Consult your physician for any health problems.
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
|
|
|
|
|
|
|
